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We developed a method to
reduce the number of energy
layers in robust IMPT treat-
ment plans without compro-
mising dosimetric plan
quality. This resulted in an
average energy layer reduc-
tion of 45% for oropharyn-
geal cases and 28% for
prostate cases. When
assuming 1, 2, or 5 seconds
energy switching time, the
delivery time per fraction
was on average shortened by
25%, 32%, or 38% for
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http://dx.doi.org/10.1016/j.ijrobp.2015.01.031Purpose: To shorten delivery times of intensity modulated proton therapy by reducing
the number of energy layers in the treatment plan.
Methods and Materials: We have developed an energy layer reduction method, which
was implemented into our in-house-developed multicriteria treatment planning system
“Erasmus-iCycle.” The method consisted of 2 components: (1) minimizing the loga-
rithm of the total spot weight per energy layer; and (2) iteratively excluding low-
weighted energy layers. The method was benchmarked by comparing a robust
“time-efficient plan” (with energy layer reduction) with a robust “standard clinical
plan” (without energy layer reduction) for 5 oropharyngeal cases and 5 prostate cases.
Both plans of each patient had equal robust plan quality, because the worst-case dose
parameters of the standard clinical plan were used as dose constraints for the time-
efficient plan. Worst-case robust optimization was performed, accounting for setup er-
rors of 3 mm and range errors of 3% þ 1 mm. We evaluated the number of energy
layers and the expected delivery time per fraction, assuming 30 seconds per beam di-
rection, 10 ms per spot, and 400 Giga-protons per minute. The energy switching time
was varied from 0.1 to 5 seconds.
Results: The number of energy layers was on average reduced by 45% (range,
30%-56%) for the oropharyngeal cases and by 28% (range, 25%-32%) for the prostate
cases. When assuming 1, 2, or 5 seconds energy switching time, the average deliverySc, Department of Radi-
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Volume 92  Number 2  2015 Shortening IMPT delivery times 461time was shortened from 3.9 to 3.0 minutes (25%), 6.0 to 4.2 minutes (32%), or 12.3 to
7.7 minutes (38%) for the oropharyngeal cases, and from 3.4 to 2.9 minutes (16%), 5.2
to 4.2 minutes (20%), or 10.6 to 8.0 minutes (24%) for the prostate cases.
Conclusions: Delivery times of intensity modulated proton therapy can be reduced
substantially without compromising robust plan quality. Shorter delivery times are
likely to reduce treatment uncertainties and costs.  2015 Elsevier Inc. All rights
reserved.Introduction
A reduction of the delivery time per fraction is likely to
have a beneficial effect on patient comfort, treatment
uncertainties, and treatment costs. Especially the last 2
motives are important for intensity modulated proton
therapy (IMPT). Compared with photon therapy, IMPT is
relatively sensitive to treatment uncertainties (1, 2), and it is
associated with higher treatment costs (3, 4).
In spot-scanned IMPT, each proton pencil beam (or
“spot”) is spatially characterized by its lateral position and
its position in depth, the latter depending on the energy of
the proton beam. Spots are delivered one by one, adjusting
the lateral position and/or energy in between the delivery
of each spot. In modern commercial double-scanning
proton delivery systems (ie systems in which the proton
beam is magnetically deflected in both lateral directions),
the energy switching time is typically in the order of
seconds, causing it to be the major component of the
delivery time (5). A reduction of the number of energy
layers in an IMPT treatment plan is therefore likely to
result in a reduction of the delivery time. However,
reducing energy layers by simply increasing the energy
layer spacing was demonstrated to result in a worsening of
the plan quality (6, 7).
In this study we hypothesized that the number of energy
layers can be reduced without affecting the plan quality,
because of the degeneracy of IMPT treatment planning.
Some treatment plans with a comparable plan quality may
contain many energy layers, whereas others contain fewer.
By taking the number of energy layers into account during
treatment planning (which is typically not done), the
solution can potentially be steered toward an outcome with
fewer energy layers. For CyberKnife treatment planning, a
similar approach resulted in treatment plans with fewer
principal beam directions, thereby reducing delivery times
in robotic radiosurgery (8).
The aim of this study was to reduce the delivery time per
fraction of robust IMPT treatment plans without compro-
mising the dosimetric plan quality. To this purpose, we
developed a method to incorporate the reduction of energy
layers in the treatment planning process. This method was
implemented into our treatment planning system and tested
by generating robust treatment plans for 5 patients with
oropharyngeal cancer and 5 patients with locally advanced
prostate cancer.Methods and Materials
Treatment planning system
The novel energy layer reduction method was implemented
into our in-house-developed treatment planning system
“Erasmus-iCycle” (7, 9). The planning system does not
optimize a single objective function that is the weighted
sum of all objectives, but it performs “prioritized” or
“lexicographic” multi-criteria optimization instead. This
means that objectives are optimized one by one according
to their priorities, which are defined a priori by the user in
the so-called “wish list.” Generally, a single wish list can be
used per patient group, which enables fully automatic
treatment planning. Automatic plan generation allows for
an objective comparison between different planning stra-
tegies and was shown to result in superior plan quality
compared with manual planning (10, 11).
Erasmus-iCycle features two planning methods for
IMPT, which are schematically illustrated in Figure 1. First,
treatment plans can be generated using the traditional
planning method in which the candidate spots are distrib-
uted over the target volume using a regular grid with a spot
spacing defined by the user (denoted as “regular grid
planning”). Second, treatment planning can be performed
using the new and more efficient “pencil beam resampling”
method, as described by Van de Water et al (7). This
method uses an iterative approach in which the multi-
criteria optimization is performed repeatedly, while add-
ing in each iteration a new sample of randomly selected
candidate spots to the obtained solution. The user has to
define the sample size and a stopping criterion to terminate
the iterative resampling process. Pencil beam resampling
was shown to reduce optimization times by a factor of 2.8
to 5.6 on average, compared with traditional regular grid
planning (7).
In Erasmus-iCycle both planning methods feature a
“spot reduction” loop (indicated in Fig. 1). After each
multi-criteria optimization, low-weighted spots and spots
with a weight below the minimum deliverable spot weight
are iteratively excluded from the solution, while con-
straining previously achieved dose parameters. The exclu-
sion of spots is terminated when further reduction results in
a violation of previously achieved dose parameters. In this
way Erasmus-iCycle will always generate deliverable plans
that are efficient in terms of the number of spots (7).
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Fig. 1. Study workflow describing treatment plan generation and comparison. The differences between the standard clinical
plan and the time-efficient plan are highlighted in red. A color version of this figure is available at www.redjournal.org.
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planning mode to generate IMPT treatment plans that are
robust against setup errors and range errors. Erasmus-iCycle
uses a “minimax” approach for this purpose (12, 13). The
nominal scenario and several error scenarios are simulta-
neously included in the multi-criteria optimization, opti-
mizing the worst scenario for each objective. In this study,
robust optimizationwas performedusing a total of 9 scenarios:
the nominal scenario (1 scenario), 3-mm setup errors in pos-
itive and negative directions along 3 axes (6 scenarios), and a
proton undershoot and overshoot of 3%þ 1mm (2 scenarios).
The proton dose calculation algorithm used for IMPT
treatment planning was developed at the Massachusetts
General Hospital and Harvard Medical School, where it is
implemented in their in-house-developed radiotherapy
platform “ASTROID” (14). The algorithm accounts for
density heterogeneities using a superpositioneconvolution
approach. In this study we used a dose grid with 3  3 
3-mm3 resolution. Available proton energies ranged from
70 to 230 MeV, with corresponding beam widths ranging
from 7 to 3 mm s (in-air at the isocenter), respectively. A
range shifter of 75 mm water-equivalent thickness could beinserted during the delivery of a field. The minimum
deliverable spot weight was 0.001 Giga-protons.
Energy layer reduction method
The energy layer reduction method that we developed in
this study consisted of 2 components. The first component
was the introduction of an additional objective, which
aimed at minimizing the logarithm of the total spot weight
per energy layer. The logarithm has a steeper gradient at
lower values, causing the optimizer to focus on the mini-
mization of spot weights in low-weighted energy layers,
thereby redistributing them to relatively high-weighted
energy layers. The second component was the iterative
exclusion of low-weighted energy layers, which was
implemented as an extension of the spot reduction loop
described above. After each multi-criteria optimization,
low-weighted energy layers were excluded from the solu-
tion first, before switching to the iterative exclusion of in-
dividual spots. The energy layer reduction was terminated
when further exclusion resulted in the violation of previ-
ously achieved dose parameters. Excluded energy layers
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sequent resampling iterations.
Patient data and dose prescription
Data of 5 patients with oropharyngeal cancer and 5 patients
with locally advanced prostate cancer were used in this
study. The oropharyngeal cases (3 unilateral and 2 bilateral
cases) were prescribed a simultaneously integrated boost of
66 Gy to the primary tumor and positive neck levels, and
54 Gy to the elective neck levels, delivered in 30 fractions.
The median high-dose clinical target volume (CTV) was
41 mL (range, 5-106 mL), whereas the median total high-
dose and low-dose CTV was 95 mL (range, 67-229 mL).
The prostate cases were prescribed a simultaneously inte-
grated boost of 74 Gy to the prostate expanded by a margin
of 4 mm, and 55 Gy to the seminal vesicles and pelvic
lymph nodes, both expanded using a margin of 7 mm.
These margins were applied to construct an internal target
volume (ITV), to account for the organ-specific inter-
fraction motion in prostate cases (15). The median high-
dose ITV was 60 mL (range, 56-65 mL), and the median
total high-dose and low-dose ITV was 875 mL (range, 810-
957 mL).
The wish lists containing the constraints and objectives
for both patient groups are given in the Supplementary
Material (available online at www.redjournal.org). The
constraints and objectives of the target volumes were cho-
sen such that the volume receiving 95% of the prescribed
dose was higher than 99% (V95% > 99%) and the volume
receiving 107% of the prescribed dose was smaller than 2%
(V107% < 2%) in all error scenarios included in the opti-
mization. For the oropharyngeal cases, we included the
salivary glands, spinal cord, brainstem, larynx, oral cavity,
and swallowing muscles as organs at risk (OARs) in the
robust optimization, whereas the rectum, bladder, and
femur heads were considered for the prostate cases. The
oropharyngeal cases were planned using a 3-beam
arrangement (gantry angles: 60, 180, and 300),
whereas the prostate cases were planned using a 2-beam
arrangement (gantry angles: 90 and 270) (15, 16).
Study design
To assess the effectiveness of the proposed energy layer
reduction method, we compared for each patient a robust
“time-efficient” IMPT plan with a robust “standard clin-
ical” IMPT plan. The study workflow is depicted in
Figure 1. First, the standard clinical plan was generated
using traditional regular grid planning without energy layer
reduction, resembling clinical practice in currently oper-
ating proton facilities. Regular grid planning was per-
formed using a lateral spot spacing of 7 mm, corresponding
to approximately 2 times the width (s) of the smallest spot
(6). The spacing between energy layers depended on the
proton energy and was set to the longitudinal width of theBragg peak (at 80% of the peak height) (6, 17). Second, the
time-efficient plan was generated using the new pencil
beam resampling method with energy layer reduction. The
worst-case dose parameters of each objective achieved in
the standard clinical plan were used as dose constraints for
the time-efficient plan, to ensure comparable robust plan
quality in both treatment plans. Pencil beam resampling
was performed using a sample size of 5000 spots per iter-
ation, which were randomly selected from a grid with
1-mm lateral spot spacing and the same energy layer
spacing as used for the standard clinical plan. Time-
efficient plan generation was terminated when the number
of energy layers could not be reduced any further in
2 consecutive resampling iterations.
We compared the worst-case dose parameters of the
CTVs (oropharyngeal cases), ITVs (prostate cases), and
OARs, considering all 9 scenarios included in the robust
optimization. Next to that, we evaluated the number of
energy layers and the expected delivery time per fraction
(ie time between the delivery of the first spot and the last
spot, excluding patient setup), which was calculated
assuming 30 seconds per beam direction (gantry rotation
and beam setup), 10 ms per spot (lateral spot adjustment),
and 400 Giga-protons per minute (beam current). The
energy switching time was varied between 0.1 and 5 sec-
onds, because this was assumed to cover the variety in
currently operating spot-scanning systems, from the PSI
Gantry 2 to a slow-switching system, respectively (18, 19).
Switching times of 1, 2, and 5 seconds were assumed to be
typical values for commercial systems and are therefore
explicitly mentioned in this article.Results
Table 1 lists the plan parameters of the standard clinical
plans and the time-efficient plans for the oropharyngeal
cases and the prostate cases. For both patient groups, the
table shows that the worst-case dose parameters were
nearly identical, indicating comparable robust plan quality
for both types of treatment plans. The number of energy
layers in the time-efficient treatment plans was on average
reduced by 45% (range, 30%-56%) for the oropharyngeal
cases and by 28% (range, 25%-32%) for the prostate cases,
compared with the standard clinical plans. The corre-
sponding delivery times per fraction are depicted in
Figure 2 as a function of the energy switching time. When
assuming energy switching times of 1, 2, or 5 seconds, the
average delivery time of the oropharyngeal cases was
shortened from 3.9 to 3.0 minutes (25%; range, 18%-30%),
from 6.0 to 4.2 minutes (32%; range, 22%-39%), or from
12.3 to 7.7 minutes (38%; range, 26%-48%). For the
prostate cases, the delivery time was reduced from 3.4 to
2.9 minutes (16%; range, 12%-19%), from 5.2 to 4.2 mi-
nutes (20%; range, 17%-23%), or from 10.6 to 8.0 minutes
(24%; range, 21%-27%) on average, when assuming energy
switching times of 1, 2, or 5 seconds, respectively. The
Table 1 Average worst-case dose parameters and delivery parameters (and range) for the standard clinical plans and the time-efficient
plans of the oropharyngeal and prostate cases. Estimated delivery times are listed for energy switching times of 1, 2, or 5 seconds
Parameter Value Standard clinical plan Time-efficient plan Relative difference (%)
Oropharyngeal cases (nZ5)
CTV-low V95% (%) 99.5 (99.3-99.7) 99.6 (99.4-99.8) 0 (0-0)
CTV-high V95% (%) 99.4 (99.0-99.8) 99.5 (99.3-99.8) 0 (0-0)
CTV-high V107% (%) 0.3 (0.1-0.7) 0.3 (0.1-0.7) 31 (40 to 113)
Parotid glands Mean (Gy) 14.1 (6.9-27.0) 14.1 (7.0-27.0) 0 (0-2)
Submandibular glands Mean (Gy) 34.7 (12.3-59.6) 34.7 (12.4-59.6) 0 (1 to 0)
Spinal cord Max (Gy) 20.7 (19.7-21.3) 20.3 (19.6-20.9) 2 (4 to 0)
Brainstem Max (Gy) 19.4 (18.3-20.4) 19.4 (18.2-20.6) 0 (10 to 13)
Larynx Mean (Gy) 18.0 (8.7-33.9) 18.0 (8.7-33.7) 0 (1 to 0)
Oral cavity Mean (Gy) 19.5 (6.8-32.7) 19.5 (6.8-32.7) 0 (1 to 0)
Swallowing muscles Mean (Gy) 23.9 (13.6-34.4) 23.8 (13.1-34.7) 1 (3 to 1)
CI-low 2.23 (1.99-2.48) 2.20 (1.93-2.43) 2 (3 to 0)
CI-high 2.19 (1.98-2.41) 2.13 (1.98-2.31) 2 (4 to 0)
Beam directions 3 (3-3) 3 (3-3) 0 (0-0)
Energy layers 126 (107-144) 71 (52-100) 45 (56 to 30)
Spots 2099 (1123-3314) 1809 (1050-2841) 12 (18 to 7)
Total spot weight (Gp) 3899 (2046-6411) 3855 (2069-6298) 1 (3 to 1)
Delivery time (1 s) (min) 3.9 (3.5-4.5) 3.0 (2.6-3.6) 25 (30 to 18)
Delivery time (2 s) (min) 6.0 (5.3-6.9) 4.2 (3.4-5.3) 32 (39 to 22)
Delivery time (5 s) (min) 12.3 (10.6-14.1) 7.7 (6.1-10.3) 38 (48 to 26)
Prostate cases (nZ5)
ITV-low V95% (%) 99.3 (99.1-99.4) 99.3 (99.1-99.4) 0 (0-0)
ITV-high V95% (%) 99.3 (98.7-99.7) 99.5 (98.8-99.8) 0 (0-0)
ITV-high V107% (%) 0.1 (0.0-0.1) 0.1 (0.0-0.3) 29 (67 to 190)
Femur left Max (Gy) 50.9 (50.5-51.3) 50.8 (50.2-51.3) 0 (2 to 0)
Femur right Max (Gy) 50.3 (48.7-51.0) 50.2 (47.8-51.1) 0 (2 to 1)
Rectum Mean (Gy) 26.3 (16.3-38.9) 26.2 (16.3-38.9) 0 (0-0)
Bladder Mean (Gy) 39.2 (34.1-43.6) 39.2 (34.1-43.6) 0 (0-0)
Femur left Mean (Gy) 27.9 (20.9-31.8) 27.9 (20.9-31.8) 0 (0-0)
Femur right Mean (Gy) 30.9 (27.9-35.5) 30.9 (27.9-35.6) 0 (0-0)
CI-low 1.61 (1.55-1.69) 1.62 (1.56-1.71) 1 (0-1)
CI-high 1.54 (1.51-1.59) 1.56 (1.51-1.59) 1 (1 to 3)
Beam directions 2 (2-2) 2 (2-2) 0 (0-0)
Energy layers 107 (101-112) 77 (72-83) 28 (32 to 25)
Spots 3835 (3445-4360) 3649 (3069-4300) 5 (15 to 8)
Total spot weight (Gp) 8326 (7867-9056) 8169 (7777-8839) 2 (2 to 1)
Delivery time (1 s) (min) 3.4 (3.3-3.5) 2.9 (2.7-3.1) 16 (19 to 12)
Delivery time (2 s) (min) 5.2 (4.9-5.4) 4.2 (3.9-4.5) 20 (23 to 17)
Delivery time (5 s) (min) 10.6 (10.0-11.0) 8.0 (7.5-8.6) 24 (27 to 21)
Abbreviations: CI-highZ high-dose conformity index; CI-lowZ low-dose conformity index; CTVZ clinical target volume; CTV/ITV-highZ high-
dose target volume; CTV/ITV-low Z low-dose target volume; Gp Z Giga-protons; ITV Z internal target volume.
The conformity index was defined as the patient volume receiving 95% of the prescription dose divided by the target volume (CTV or ITV).
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are provided in the Supplementary Material (available
online at www.redjournal.org).
The worst-case doseevolume histograms of both treat-
ment plans for 1 oropharyngeal case and 1 prostate case are
displayed in Figure 3. The worst-case doseevolume his-
tograms were constructed by taking for each doseevolume
point the worst value from the 9 scenarios included in the
optimization (nominal, 3-mm setup errors, 3% þ 1-mm
range errors). The curves are generally located very close to
each other, indicating a good agreement between the
standard clinical plans and the time-efficient plans. Figure 4
shows for both cases the corresponding total dosedistributions and the doses per field for the nominal sce-
nario. The total dose distributions of the standard clinical
plans and the time-efficient plans were very similar, espe-
cially for the oropharyngeal case. Larger differences can be
observed in the dose distributions of the individual fields,
illustrating the degeneracy of IMPT treatment plans. For
the oropharyngeal case, the intensity of the individual fields
could differ between both types of plans. For the prostate
case, a change in the spatial distribution can be observed,
indicating a redistribution of the spots within the remaining
energy layers in the time-efficient plan.
The total spot weight per energy layer is depicted in
Figure 5 for the same cases as shown in Figures 3 and 4.
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redistribution of spots from low-weighted energy layers to
high-weighted energy layers, which was observed most
strongly for the oropharyngeal case. The graphs show that
the energy layers were not excluded evenly from all beam
directions or uniformly across the proton energy range.
Furthermore, the excluded low-weighted energy layers did
not necessarily correspond to low proton energies, as
illustrated by beam 3 of the oropharyngeal case.Discussion
This study shows that the number of energy layers in robust
IMPT treatment plans can be reduced considerably without
affecting the dosimetric plan quality. This can result in a
substantial shortening of the delivery time.
It should be noted that the delivery times reported in this
study did not include the time required for patient setup.
The relative gain in overall treatment efficiency will
therefore depend on the patient setup time and on the
number of treatment rooms that share the proton beam. In
multi-room centers, patient setup can take place while pa-
tients in other treatment rooms are irradiated. If patientsetup can be completed within the delivery time in other
rooms, a shortening of the delivery time will reduce the
beam waiting time and enable more efficient use of mul-
tiple treatment rooms. This can result in an increase in the
number of treated patients and subsequently in a reduction
of treatment costs. Regardless of the type of facility, de-
livery time reduction may also improve patient comfort and
reduce treatment uncertainties, because intrafraction dis-
placements of, for example, spine, prostate, and liver tu-
mors tend to increase with delivery time (20-23).
Very recently, Cao et al (24) published an alternative
method to reduce energy layers in IMPT treatment plans.
They proposed a mixed-integer programming approach,
iteratively reducing the number of energy layers until the plan
quality degraded beyond a user-defined level. The number of
energy layers in nonrobust IMPT treatment plans was
reduced by 14% to 19% for prostate cases, by 11% for a lung
case, and by 26% for amesothelioma case, when allowing for
the cost-function value to worsen by 5%. Our study shows
that energy layer reduction can also be performed for robust
IMPT treatment plans and without compromising dosimetric
plan quality. The larger energy layer reduction observed in
this study (25%-56% vs 11%-26% by Cao et al) might be
explained by differences between both methods or by
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on the performance of the different components of our
method are provided in the Supplementary Material (avail-
able online at www.redjournal.org).
A reduction of the number of energy layers can also be
achieved by an enlargement of the energy layer spacing, but
this was shown to compromise plan quality (6, 7). We
verified this for one oropharyngeal case by generating a
standard clinical plan using an energy layer spacing
increased by a factor of 2. The lateral spot spacing was
reduced to keep the total number of optimized spots
approximately the same. This resulted in an energy layer
reduction (50%) that was comparable to the reduction in the
time-efficient plan of this patient (52%). However, worst-
case doses in the submandibular glands were increased by7.1 Gy (þ33%, mean dose), in the spinal cord by 3.3 Gy
(þ17%, maximum dose), in the larynx by 13.0 Gy
(þ149%, mean dose), in the oral cavity by 5.2 Gy (þ30%,
mean dose), and in the swallowing muscles by 12.1 Gy
(þ68%, mean dose), compared with the time-efficient plan.
These results confirm that energy layers cannot be
excluded before the start of treatment planning without
compromising plan quality. Energy layer reduction should
be incorporated in the planning process, because it makes
use of the interchangeability of spots within and between
the applied beam directions. This might also explain why
fewer energy layers were excluded in the prostate cases.
For these patients, it is more difficult to exchange spots
between beam directions, because the pelvic lymph nodes
on either side of the patient were mainly irradiated from a
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Fig. 5. Total spot weight per energy layer for each beam direction of the standard clinical plan (blue) and the time-efficient
plan (red) of the oropharyngeal and prostate cases depicted in Figures 3 and 4. A color version of this figure is available at
www.redjournal.org.
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effect of other patient and plan characteristics (eg tumor
size, tissue heterogeneities, beam directions) on the per-
formance of energy layer reduction should be investigated
in future research.
The number of energy layers was incorporated in the
mathematical optimization by means of the logarithm of
the total spot weight per energy layer. However, the loga-
rithm is a concave function, and this can give problems
during optimization. As a consequence, it required
16.7 hours on average to complete the fully automated
energy layer reduction. It would therefore be useful to find
a convex function to include the number of energy layers in
the mathematical optimization.Conclusions
The number of energy layers in robust IMPT treatment
plans can be reduced considerably without affecting the
dosimetric plan quality. The method presented in this
study resulted in an average energy layer reduction of
45% and 28% for oropharyngeal and prostate cases,
respectively. When assuming 1, 2, or 5 seconds energy
switching time, the delivery time was on averageshortened by 25%, 32%, or 38% for the oropharyngeal
cases, and by 16%, 20%, or 24% for the prostate cases.
Shorter delivery times are likely to reduce treatment un-
certainties and costs.References
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